Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_assertion type Assertion NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_head.
- NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_assertion description "[The proportion of individuals with innate slow mEPHX activity (homozygotes) was significantly higher in both the COPD group and the emphysema group than in the control group (COPD 13 [19%] vs control 13 [6%]; emphysema 21 [22%] vs 13 [6%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_provenance.
- NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_assertion evidence source_evidence_literature NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_provenance.
- NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_assertion SIO_000772 10193341 NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_provenance.
- NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_assertion wasDerivedFrom befree-20140225 NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_provenance.
- NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_assertion wasGeneratedBy ECO_0000203 NP440106.RAmnmyQN7FkwTO8XMfZP6o8rZSbn0lv-FXJLcSrvCixlA130_provenance.